These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 22335075)

  • 1. [GPs: patients require you to doubt! Interview by Catherine Holué].
    Viollet V
    Rev Prat; 2012 Jan; 62(1):85-6. PubMed ID: 22335075
    [No Abstract]   [Full Text] [Related]  

  • 2. [Rare diseases: an "exceptional field of research. Interview by Catherine Holué].
    Dolfus H; Lévy N
    Rev Prat; 2012 Jan; 62(1):89-90. PubMed ID: 22335076
    [No Abstract]   [Full Text] [Related]  

  • 3. [Rare diseases: "a public health priorty". Interview by Catherine Holué].
    Podeur A
    Rev Prat; 2012 Jan; 62(1):79-80. PubMed ID: 22335073
    [No Abstract]   [Full Text] [Related]  

  • 4. [Operability of databases].
    Landais P
    Presse Med; 2012 May; 41 Suppl 1():S39-40. PubMed ID: 22459991
    [No Abstract]   [Full Text] [Related]  

  • 5. [Health technology assessment in the field of rare diseases at Haute Autorité de Santé in France].
    Bélorgey C
    Med Sci (Paris); 2018 May; 34 Hors série n°1():49-50. PubMed ID: 29911564
    [No Abstract]   [Full Text] [Related]  

  • 6. Rare diseases are a 'common' problem for clinicians.
    Elliott E; Zurynski Y
    Aust Fam Physician; 2015 Sep; 44(9):630-3. PubMed ID: 26488039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rare pulmonary diseases: a common fight.
    Harari S; Humbert M
    Eur Respir Rev; 2017 Sep; 26(145):. PubMed ID: 28877977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The stakes of pre- and post-market authorization development and clinical assessment].
    Schwebig A
    Presse Med; 2012 May; 41 Suppl 1():S6-8. PubMed ID: 22483770
    [No Abstract]   [Full Text] [Related]  

  • 9. [Communication and leadership in health care].
    Nordby H; Botten G
    Tidsskr Nor Laegeforen; 2007 Apr; 127(8):1080-2. PubMed ID: 17457397
    [No Abstract]   [Full Text] [Related]  

  • 10. Editorial: My doctor was simply unaware of this disorder..
    Margolis SA
    Aust Fam Physician; 2015 Sep; 44(9):615. PubMed ID: 26775299
    [No Abstract]   [Full Text] [Related]  

  • 11. ["Orphan diseases"--the orphans of medicine].
    Schenk M
    Dtsch Med Wochenschr; 2010 Apr; 135(16):p15. PubMed ID: 20669526
    [No Abstract]   [Full Text] [Related]  

  • 12. [Rare diseases in Lebanon: diagnostic difficulties and therapy].
    Mansour H
    Arch Pediatr; 2015 May; 22(5 Suppl 1):1-2. PubMed ID: 26112493
    [No Abstract]   [Full Text] [Related]  

  • 13. [Documentary research and self-instruction. Critical reading of a medical article. Practice guidelines. Part 1: rare diseases].
    Cordier JF; Aymé S
    Rev Prat; 2004 Apr; 54(7):777-9. PubMed ID: 15253297
    [No Abstract]   [Full Text] [Related]  

  • 14. [Rare diseases, definitions and epidemiology].
    Donnart A; Viollet V; Roinet-Tournay M
    Soins Pediatr Pueric; 2013; (274):14-6. PubMed ID: 24228328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Future physicians--seen from the experienced physician's point of view].
    Kistrup KR; Lundvall L
    Ugeskr Laeger; 2004 Dec; 166(51):4710-1. PubMed ID: 15669529
    [No Abstract]   [Full Text] [Related]  

  • 16. Rare diseases in general practice: recognising the zebras among the horses.
    Evans WR; Rafi I
    Br J Gen Pract; 2016 Nov; 66(652):550-551. PubMed ID: 27789486
    [No Abstract]   [Full Text] [Related]  

  • 17. A powerful team: the family physician advocating for patients with a rare disease.
    Dudding-Byth T
    Aust Fam Physician; 2015 Sep; 44(9):634-8. PubMed ID: 26488040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. General knowledge and awareness on rare diseases among general practitioners in Bulgaria.
    Miteva Ts; Jordanova R; Iskrov G; Stefanov R
    Georgian Med News; 2011 Apr; (193):16-9. PubMed ID: 21617267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What role does the general practitioner in France play among cancer patients during the initial treatment phase with intravenous chemotherapy? A qualitative study.
    Coindard G; Barrière J; Vega A; Patrikidou A; Saldanha-Gomes C; Arnould P; Combessie P; Ourabah R
    Eur J Gen Pract; 2016 Jun; 22(2):96-102. PubMed ID: 26799829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rare diseases: what's next?
    Remuzzi G; Garattini S
    Lancet; 2008 Jun; 371(9629):1978-9. PubMed ID: 18555899
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.